文献速递类风湿关节炎

驱动炎性关节炎软骨再生的中性粒细胞胞外囊泡的分子决定因素

Molecular Determinants of Neutrophil Extracellular Vesicles That Drive Cartilage Regeneration in Inflammatory Arthritis.
PubMed 文献 · Arthritis Rheumatol · 2024-08-16

本研究在血清转移诱导的炎性关节炎小鼠模型中经关节腔内给予中性粒细胞胞外囊泡(EVs),发现其保护软骨、增加胶原II并减少胶原X表达,RNA测序显示5,231个基因差异表达(P < 0.05),其中257个为EV治疗特有。EVs影响Wnt和Notch等再生通路,miR-455-3p在健康供者和类风湿关节炎(RA)患者EVs中均可检测到,且EVs对软骨细胞发挥抗分解代谢效应可被miR-455-3p antagomir阻断。

要点

  • 中性粒细胞EVs经关节腔内给药在血清转移诱导小鼠关节炎中保护软骨,增加胶原II并减少胶原X表达。
  • 关节RNA测序显示5,231个基因差异表达(P < 0.05),257个为EV治疗特有,涉及Wnt和Notch信号通路。
  • RA患者中性粒细胞EVs的组成、疗效和miR-455-3p含量与健康志愿者相似,提示可开发为自体治疗。

核心结论

  • RA患者中性粒细胞来源的EVs在组成、疗效和miR-455-3p含量上与健康志愿者相似,提示中性粒细胞EVs可被开发为保护与修复炎性关节炎患者关节组织的自体治疗。

研究设计与样本

  • 研究在雄性C57BL/6小鼠血清转移诱导的炎性关节炎模型中,通过预防性或治疗性方案经关节腔内给予中性粒细胞EVs。
  • 对EV给药后关节、naive与关节炎小鼠(未治疗;n = 4/组)及EV治疗患病小鼠(关节腔内给药)与对侧(载体治疗;n = 8/组)进行膝关节转录组分析。
  • 比较健康供者与RA患者中性粒细胞EVs。

主要发现

  • EVs提供软骨保护,关节内胶原II表达增加、胶原X表达减少。
  • 关节RNA测序共5,231个基因差异表达(P < 0.05),其中257个为EV治疗特有。
  • EVs影响关节发育相关关键再生通路,包括Wnt和Notch信号。
  • EVs中鉴定出10个与RA相关的microRNAs;miR-455-3p在健康供者和RA EVs中均可检测到。
  • EV加入软骨细胞培养可升高miR-455-3p,并在白细胞介素-1β刺激下发挥抗分解代谢效应,该效应可被放线菌素或miR-455-3p antagomir阻断。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study was undertaken to establish the potential therapeutic profile of neutrophil-derived extracellular vesicles (EVs) in experimental inflammatory arthritis and associate pharmacological activity with specific EV components, focusing on microRNAs. METHODS: Neutrophil EVs were administered intra-articularly through a prophylactic or therapeutic protocol to male C57BL/6 mice undergoing serum-transfer-induced inflammatory arthritis. Transcriptomic analysis of knees was performed on joints following EV administration, naive and arthritic mice (untreated; n = 4/group) and EV-treated diseased mice (intra-articular administration) with contralateral (vehicle-treated; n = 8/group). Comparison of healthy donor and patients with rheumatoid arthritis (RA) neutrophil EVs was performed. RESULTS: EVs afforded cartilage protection with an increase in collagen-II and reduced collagen-X expression within the joint. To gain mechanistic insights, RNA sequencing of the arthritic joints was conducted. A total of 5,231 genes were differentially expressed (P < 0.05), with 257 unique to EV treatment. EVs affected key regenerative pathways involved in joint development, including Wnt and Notch signaling. This wealth of genomic alteration prompted to identify microRNAs in EVs, 10 of which are associated with RA. As a proof of concept, we focused on miR-455-3p, which was detected in both healthy donor and RA EVs. EV addition to chondrocyte cultures elevated miR-455-3p and exerted anticatabolic effects upon interleukin-1β stimulation; these effects were blocked by actinomycin or miR-455-3p antagomir. CONCLUSION: Neutrophils from patients with RA yielded EVs with composition, efficacy, and miR-455-3p content similar to those of healthy volunteers, suggesting that neutrophil EVs could be developed as an autologous treatment to protect and repair joint tissue of patients affected by inflammatory arthritides.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Thomas BL, Montero-Melendez T, Oggero S, et al. Molecular Determinants of Neutrophil Extracellular Vesicles That Drive Cartilage Regeneration in Inflammatory Arthritis. Arthritis Rheumatol. 2024. PMID: 39041647. doi:10.1002/art.42958

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。